Radiofrequency Ablation for Lumbar Spondylosis
(LMB-RFA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method for radiofrequency ablation, a treatment aimed at reducing pain from lumbar spondylosis (a type of arthritis in the lower back). Researchers aim to determine if a new procedure, the parasagittal approach, is more effective than the traditional method. Participants will receive the traditional approach on one side of the back and the new approach on the other to compare results. The trial seeks individuals who have experienced low back pain for at least six months and have not found relief from standard treatments like medication and physical therapy. As an unphased trial, this study offers a unique opportunity to explore innovative treatment options that could potentially provide pain relief where other treatments have failed.
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. However, it mentions that participants should have failed conservative treatment, including nonsteroidal anti-inflammatory medications, which might imply that these medications are not effective for you.
What prior data suggests that this radiofrequency ablation technique is safe for lumbar spondylosis?
Research has shown that radiofrequency ablation (RFA) is generally safe for treating chronic low back pain, including lumbar spondylosis. The traditional RFA method for lumbar medial branch nerves effectively reduces pain with minimal risks, often providing relief without major side effects.
The new parasagittal approach, though less studied, aims to achieve the same pain reduction by heating specific nerves. While both treatments are similar, the parasagittal approach might better target the nerves. Its safety is expected to match the traditional method due to the similarity in procedures and goals.
Both RFA methods have been used without major safety concerns, making them promising options for managing chronic back pain.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it's exploring two different techniques for radiofrequency ablation (RFA) in treating lumbar spondylosis, a common cause of back pain. Unlike traditional RFA, which targets nerves at a specific angle to avoid certain ligaments, the new parasagittal approach aims to place the electrode more parallel to the nerve, potentially improving nerve coagulation. This could enhance the effectiveness of RFA by ensuring better nerve targeting, offering a promising alternative to existing pain management options like medications or physical therapy. This trial could help refine RFA to provide more consistent pain relief for patients suffering from chronic back issues.
What evidence suggests that this trial's approaches to radiofrequency ablation could be effective for lumbar spondylosis?
Research has shown that radiofrequency ablation (RFA) effectively treats lower back arthritis, providing long-lasting pain relief and improving quality of life for many with persistent lower back pain. One study found that RFA targeting the nerves in the lower back offers significant and lasting pain relief. Another study reported improvements in daily activities and patient satisfaction after the procedure. In this trial, participants will receive RFA using both traditional and new parasagittal methods. The traditional method effectively targets the nerves, while the parasagittal method aims to enhance treatment by positioning the electrode more precisely.678910
Who Is on the Research Team?
Yakov Vorobeychik, MD PhD
Principal Investigator
Professor, Department of Anesthesiology
Are You a Good Fit for This Trial?
This trial is for individuals with lumbar spondylosis, a condition affecting the lower back. Participants should be candidates for radiofrequency ablation therapy, which is a treatment to reduce pain by heating nerve tissue. Specific eligibility details are not provided.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo bilateral radiofrequency ablation (RFA) using both traditional and parasagittal approaches
Follow-up
Participants are monitored for safety and effectiveness after treatment, including self-reported analgesic consumption and pain intensity
What Are the Treatments Tested in This Trial?
Interventions
- Radiofrequency Ablation of Lumbar Medial Branch Nerves
Find a Clinic Near You
Who Is Running the Clinical Trial?
Milton S. Hershey Medical Center
Lead Sponsor